drug
eliglustat tartrate
Marketedupdated 2mo agoby Aizant Drug Research Solutions Pvt Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 24, 2030
~4.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (5)
- Dec 13, 2038method-of-use (U-3040)US 10888544
- Jun 5, 2032method-of-use (U-3043)US 12465586
- Jan 31, 2031method-of-use (U-3043)US 108885474.5y
- Nov 24, 2030compositionUS 114581194.3y
- Jun 26, 2026compositionUS 7196205
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that